Showing results (1191-1200 of 1,342) with videos related to
Sort By:
Pageof 135
Neuro-Oncology Advances|May 19, 2023
Systemic immune derangements are shared across various CNS pathologies and reflect novel mechanisms of immune privilegeSelena J Lorrey, Jessica Waibl Polania, Lucas P Wachsmuth, et al.Neuro-Oncology Advances|March 14, 2023
The PARP inhibitor Rucaparib synergizes with radiation to attenuate atypical teratoid rhabdoid tumor growthIrina Alimova, Gillian Murdock, Angela Pierce, et al.Neuro-Oncology Advances|March 14, 2023
Clinical outcome of biomarker-guided therapies in adult patients with tumors of the nervous systemMirjam Renovanz, Sylvia C Kurz, Johannes Rieger, et al.Neuro-Oncology Advances|March 27, 2023
Epidemiological trends, prognostic factors, and survival outcomes of synchronous brain metastases from 2015 to 2019: a population-based studyMegan Parker, Kelly Jiang, Jordina Rincon-Torroella, et al.Neuro-Oncology Advances|August 11, 2022
Associations of levetiracetam use with the safety and tolerability profile of chemoradiotherapy for patients with newly diagnosed glioblastomaKatharina Seystahl, Felix Boakye Oppong, Emilie Le Rhun, et al.Neuro-Oncology Advances|August 12, 2022
Erratum to: Rapid early progression (REP) of glioblastoma is an independent negative prognostic factor: Results from a systematic review and meta-analysisNeuro-Oncology Advances|August 15, 2022
Phase I trial of adjuvant mature autologous dendritic cell/allogeneic tumor lysate vaccines in combination with temozolomide in newly diagnosed glioblastomaIan F Parney, S Keith Anderson, Michael P Gustafson, et al.Neuro-Oncology Advances|August 1, 2022
Prognostic impact of PDGFRA gain/amplification and MGMT promoter methylation status in patients with IDH wild-type glioblastomaNayuta Higa, Toshiaki Akahane, Seiya Yokoyama, et al.Neuro-Oncology Advances|August 3, 2022
Rapid intraoperative diagnosis of pediatric brain tumors using Raman spectroscopy: A machine learning approachRashad Jabarkheel, Chi-Sing Ho, Adrian J Rodrigues, et al.Neuro-Oncology Advances|May 5, 2021
ABCB1 inhibition provides a novel therapeutic target to block TWIST1-induced migration in medulloblastomaAishah Nasir, Alice Cardall, Ramadhan T Othman, et al.Pageof 135